| Primary |
| Atrial Fibrillation |
45.2% |
| Hypertension |
17.8% |
| Cerebrovascular Accident Prophylaxis |
5.3% |
| Prophylaxis |
3.9% |
| Thrombosis Prophylaxis |
3.0% |
| Diabetes Mellitus |
2.8% |
| Cardiac Failure |
2.7% |
| Cardiac Failure Chronic |
2.5% |
| Gastritis |
2.0% |
| Insomnia |
2.0% |
| Hyperlipidaemia |
1.9% |
| Constipation |
1.7% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Hyperuricaemia |
1.6% |
| Arrhythmia |
1.4% |
| Angina Pectoris |
0.9% |
| Benign Prostatic Hyperplasia |
0.9% |
| Chronic Obstructive Pulmonary Disease |
0.9% |
| Cerebral Infarction |
0.8% |
| Dementia |
0.8% |
|
| Cerebral Infarction |
24.8% |
| Embolic Stroke |
8.3% |
| Renal Impairment |
6.9% |
| Drug Ineffective |
6.2% |
| Interstitial Lung Disease |
6.2% |
| Wrong Technique In Drug Usage Process |
6.2% |
| Shock Haemorrhagic |
5.5% |
| Pulmonary Alveolar Haemorrhage |
4.8% |
| Melaena |
3.4% |
| Transient Ischaemic Attack |
3.4% |
| Drug Effect Incomplete |
2.8% |
| Lung Neoplasm Malignant |
2.8% |
| Pneumonia |
2.8% |
| Sepsis |
2.8% |
| White Blood Cell Count Decreased |
2.8% |
| Cardiac Failure Congestive |
2.1% |
| Dizziness |
2.1% |
| Eosinophilic Pneumonia |
2.1% |
| Haemoptysis |
2.1% |
| Haemorrhage |
2.1% |
|
| Secondary |
| Atrial Fibrillation |
39.6% |
| Prophylaxis |
14.2% |
| Hypertension |
9.0% |
| Cerebrovascular Accident Prophylaxis |
8.0% |
| Thrombosis Prophylaxis |
4.2% |
| Cardiac Failure |
2.8% |
| Chronic Atrial Fibrillation |
2.8% |
| Embolic Stroke |
2.8% |
| Blood Pressure Decreased |
1.9% |
| Chronic Bronchitis |
1.9% |
| Neurogenic Bladder |
1.9% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.9% |
| Gastritis |
1.4% |
| Hyperlipidaemia |
1.4% |
| Hyperuricaemia |
1.4% |
| Anaemia |
0.9% |
| Benign Prostatic Hyperplasia |
0.9% |
| Cerebral Infarction |
0.9% |
| Cerebrovascular Accident |
0.9% |
| Constipation |
0.9% |
|
| Cerebral Infarction |
11.3% |
| Renal Impairment |
7.5% |
| Sepsis |
7.5% |
| Haematuria |
5.7% |
| Haemoptysis |
5.7% |
| Interstitial Lung Disease |
5.7% |
| Melaena |
5.7% |
| Radioisotope Scan Abnormal |
5.7% |
| Wrong Technique In Drug Usage Process |
5.7% |
| Asphyxia |
3.8% |
| Diabetes Mellitus |
3.8% |
| Fall |
3.8% |
| Heat Illness |
3.8% |
| Hypoxia |
3.8% |
| Liver Disorder |
3.8% |
| Lung Neoplasm Malignant |
3.8% |
| Mediastinal Abscess |
3.8% |
| Neoplasm Prostate |
3.8% |
| Non-alcoholic Steatohepatitis |
3.8% |
| Aplasia Pure Red Cell |
1.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
24.7% |
| Rheumatoid Arthritis |
14.2% |
| Atrial Fibrillation |
9.6% |
| Prophylaxis |
8.2% |
| Hypertension |
6.4% |
| Cardiac Failure |
5.9% |
| Constipation |
2.7% |
| Cough |
2.7% |
| Embolic Stroke |
2.7% |
| Osteoporosis |
2.7% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.7% |
| Thrombosis Prophylaxis |
2.7% |
| Back Pain |
1.8% |
| Benign Prostatic Hyperplasia |
1.8% |
| Dementia Alzheimer's Type |
1.8% |
| Diabetes Mellitus |
1.8% |
| Dizziness |
1.8% |
| Gastric Ulcer |
1.8% |
| Gastritis |
1.8% |
| Insomnia |
1.8% |
|
| Cerebral Infarction |
7.7% |
| Rash |
7.7% |
| Restlessness |
7.7% |
| Stomatitis |
7.7% |
| Tuberculosis |
7.7% |
| Tubulointerstitial Nephritis |
7.7% |
| Atrial Fibrillation |
3.8% |
| Cholecystitis Acute |
3.8% |
| Death |
3.8% |
| Drug-induced Liver Injury |
3.8% |
| Haemoglobin Decreased |
3.8% |
| Hepatitis Fulminant |
3.8% |
| Hypokalaemia |
3.8% |
| Lung Neoplasm Malignant |
3.8% |
| Pneumonia |
3.8% |
| Pneumonia Aspiration |
3.8% |
| Prothrombin Time Prolonged |
3.8% |
| Pyrexia |
3.8% |
| Rash Generalised |
3.8% |
| Renal Failure Acute |
3.8% |
|